Paclitaxel (Taxol)



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Lung Carcinoma Cell Type Unspecified Stage Iii 100.0%
Unresponsive To Stimuli 12.9%
Neutropenia 9.7%
Pyrexia 9.7%
Acute Myeloid Leukaemia 6.5%
Drug Hypersensitivity 6.5%
Neutrophil Count Decreased 6.5%
Vomiting 6.5%
Back Pain 3.2%
Constipation 3.2%
Dyspnoea 3.2%
Ejection Fraction Decreased 3.2%
Flushing 3.2%
Hepatic Function Abnormal 3.2%
Hypophagia 3.2%
Ileus 3.2%
Lymphadenopathy 3.2%
Lymphocyte Count Decreased 3.2%
Non-cardiac Chest Pain 3.2%
Paraesthesia 3.2%
Pneumoperitoneum 3.2%